These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 5916119)

  • 1. Clinical results of treatment with megestrol acetate in menstrual disorders and contraception.
    Palti Z
    Indian Pract; 1966 Aug; 19(8):597-600. PubMed ID: 5916119
    [No Abstract]   [Full Text] [Related]  

  • 2. [Description of a new method of ovarian inhibition: the "sequential method". Results of its use in the treatment of dysmenorrheas and inter-menstrual disorders. (Study of 172 subjects treated during 573 cycles)].
    Gueguen J
    Rev Fr Gynecol Obstet; 1967 Jun; 62(6):279-86. PubMed ID: 4193181
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical and biochemical effects of megestrol acetate allone and two megestrol acetate-estrogen combinations in gynecological indications].
    Arnold M; Richter RH; Roth F
    Z Geburtshilfe Gynakol; 1969 Oct; 171(2):125-44. PubMed ID: 5355553
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical experience and ultramicroscopic findings with quingestanol acetate].
    Goisis M; Oppo GT; Forti L
    Minerva Ginecol; 1972 Mar; 24(4):180-201. PubMed ID: 4603398
    [No Abstract]   [Full Text] [Related]  

  • 5. [A new association of megestrol acetate and ethinyl estradiol in gynecologic therapy. Preliminary results].
    Signorelli I; Emanueli A
    Minerva Ginecol; 1969 Apr; 21(8):512-22. PubMed ID: 5815438
    [No Abstract]   [Full Text] [Related]  

  • 6. [Lutenyl and menstrual disorders. A hospital study].
    Cohen A; Engelmann P; Erny R; Favier M; Ghéron G
    Rev Fr Gynecol Obstet; 1988 Nov; 83(11):741-3. PubMed ID: 3206099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The oral progestational and anti-ovulatory properties of megestrol acetate and its therapeutic use in gynaecological disorders.
    Ostergaard E
    J Obstet Gynaecol Br Emp; 1965 Feb; 72(1):45-48. PubMed ID: 12332461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of the preparation dl-13-ethyl-17-alpha-ethinyl-17-beta-hydroxy-4-gonen-3-on (WY 3707) in combination with ethinyl estradiol in gynecologic treatment and contraception].
    Misinger I; Krobová I; Moravcová V
    Cesk Gynekol; 1968 Jun; 33(5):329-32. PubMed ID: 5662271
    [No Abstract]   [Full Text] [Related]  

  • 9. [Use of nomegestrol acetate in the treatment of menstruation disorders. Our experience in 56 cases].
    Persiani P; Radici E; Lombardi PA; Lombardi PL
    Minerva Ginecol; 1997 Apr; 49(4):181-5. PubMed ID: 9206771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Oral treatment of prolonged dysfunctional bleedings with estrogen-gestagen preparations].
    Rehsteiner HP
    Zentralbl Gynakol; 1969 Feb; 91(6):178-86. PubMed ID: 5405176
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical use of an oral gestagen, Sapilon].
    Murai ; Okada M; Obarasawa H; Osawa S; Aida R
    Sanfujinka No Jissai; 1969 Sep; 18(9):874-8. PubMed ID: 5394771
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical use of an estro-progestinic association in "sequential" treatment].
    Scaglione V; Arrotta U
    Attual Ostet Ginecol; 1968; 14(6):467-88. PubMed ID: 5738121
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapeutic effect after oral gestagens in a case of adrenogenital syndrome].
    Gitsch E
    Zentralbl Gynakol; 1970 Jul; 92(27):867-9. PubMed ID: 5497103
    [No Abstract]   [Full Text] [Related]  

  • 14. [Use of retroprogesterone].
    Hauser GA
    Ther Umsch; 1970 Oct; 27(10):709-10. PubMed ID: 5512729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Development of serial clinical study on mifepristone used as contraception].
    Xiao BL; Wu SC
    Zhonghua Fu Chan Ke Za Zhi; 2003 Aug; 38(8):499-501. PubMed ID: 14627042
    [No Abstract]   [Full Text] [Related]  

  • 16. Response to contraception. The development of systemic chemical contraceptives.
    Applezweig N
    Major Probl Obstet Gynecol; 1973; 5():17-37. PubMed ID: 4592754
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical studies with synthetic gestagens].
    Tóth F; Horn B; Primász P
    Orv Hetil; 1969 Jul; 110(30):1723-7. PubMed ID: 5801101
    [No Abstract]   [Full Text] [Related]  

  • 18. [Progestational hormones].
    Donayre J
    Rev Soc Peru Endocrinol; 1966 Jun; 3(1):79-88. PubMed ID: 5950273
    [No Abstract]   [Full Text] [Related]  

  • 19. Our experience with sequential estrogen-progestin treatments to inhibit ovulation.
    Cittadini E; Quartararo P; Romano F
    Int J Fertil; 1969; 14(2):180-7. PubMed ID: 4181574
    [No Abstract]   [Full Text] [Related]  

  • 20. [Long-cycle oral contraceptives--a progress?].
    Kvan E; Narum S
    Tidsskr Nor Laegeforen; 2005 Aug; 125(16):2202-3. PubMed ID: 16138136
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.